As a medical start-up company originating from Chiba University, we have been promoting our 2021 business to realize our mission since our founding, which is "to save as many patients as possible by smartly solving problems in emergency and acute care settings with technology and flexible and original ideas". The "Smart119 emergency medical information service," which has been in operation in Chiba City from 2020, has been continuously improved to address issues in the field, and AI predictive diagnosis algorithms based on field data which have been developed and implemented. In recognition of the system's ability to respond immediately to changing demands for emergency medical services and its future potential, the company was selected as the operator of a demonstration experiment sponsored by a local government. In addition, we have been steadily adding functions to our "disaster crisis management service, respon:sum," in response to Covid-19. Our efforts have been well received, and we have raised approximately 300 million yen through a third-party allocation of new shares.
Taka-aki Nakada, CEO and Representative Director, said, "We are engaged in businesses that utilize a variety of technologies to overcome challenges that cannot be solved by medical technology alone. The year 2021, which began in the midst of Covid-19 pandemic, was a year in which various medical issues became apparent, such as "clusters in hospitals," "adverse reactions after vaccination," and "difficulties in bringing infected pregnant women to emergency rooms," and there were many opportunities for us to quickly address and improve these issues. By proactively adding functions to "respon:sum," we were able to support the business continuity of medical institutions in a variety of emergency situations. "Smart119" has been selected for a demonstration experiment by a local government outside Chiba Prefecture, and the development of an AI predictive diagnosis algorithm for stroke has been completed. Our proactive efforts to implement the results of medical research into society using ICT and AI have been highly evaluated, and in addition to additional investment from existing shareholders, we were able to receive new investment from Sony and PKHSA funds. In 2022, we will continue to accelerate the strengthening of our business and development to deliver the latest medical care throughout Japan and build a future medical care system where everyone can feel secure.

■Results for 2021
【1: Response to the new coronavirus infection】
A number of functions have been added to the Disaster Crisis Management Service "respon:sum".
　3rd wave October 2020 - February 2009
　　　　 December 2020: "Staff health management function" added to respon:sum.
　　　　　　［Objective] To deter clusters in hospitals
　4th wave March to June 2021
　　　　 March: "Health management function for employees after vaccination" added to respon:sum
　　　　　　［Objective] Management of adverse reactions after vaccination of healthcare workers
　　　　 June: Added a "bulletin board function" to respon:sum.
　　　　　　［Objective] To gather knowledge on treatment and prevention measures in response to the emergence of delta strains.
　　　　 July: Released an application for digital devices to respon:sum.
　　　　　　［Objective] To promote the use of digital devices by employees and to support remote work such as home nursing.
　5th wave June to September 2021
　　　　 September: "Deployed department function" was added to respon:sum.
　　　　　　［Objective] To support organized disaster medical activities
　　　　September: Development and operation of "COVI-CO" (Covid-19 Coordination Powered by respon:sum), a support system for coordination of hospitalization of pregnant and nursing women with Covid-19, has started.
　　　　　　［Objective] To solve the difficulty of bringing infected pregnant and nursing women to emergency rooms
　　　 November: "COVI-CO" introduced in Chiba Prefecture

【2: AI predictive diagnosis algorithm developed and put to practical use】
We have completed the development of the "Stroke AI Predictive Diagnosis Algorithm," which was adopted by the Japan Agency for Medical Care Development (AMED) for its R&D project "Research and Development of Emergency Medical Care Prediction," a project for developing technologies for advanced medical equipment and systems. This function will be added to "Smart119," an emergency medical information service, and is expected to improve the life-saving rate and reduce subsequent injuries. Starting with the introduction of the system to the Chiba City Fire Department (during fiscal 2021), AI predictive diagnosis will be implemented in society. The research paper has been published in the international scientific journal "Scientific Reports" (published by Nature Research in the UK).

【3: Adopted as a government innovation project】
In September, "Smart119," an emergency medical information service, was adopted for the "TRY! YAMANASHI! Demonstration Experiment Support Project" sponsored by Yamanashi Prefecture. A demonstration experiment will be conducted in Yamanashi City in southeastern Yamanashi Prefecture until March 2022 to verify the development and operation of a system optimized for the region, including the elimination of difficulties in bringing in emergency medical services and the improvement of the time required to receive medical services.

【4: Support from four venture capital firms】
In August, we raised a total of 306.75 million yen in funding from Nissay Capital Corporation, MSI Capital Corporation, Sony Innovation Fund, GK PKSHA Technology Capital, and Sparks AI & Technologies Investment Co.

【5: Enhancement of sales and business development structure】
In addition to enhancing our technology development system, Smart119 Inc. is also focusing on expanding our sales and business development system so that our services can be used by many medical institutions and healthcare professionals. The current leader of the sales division is Minako Koga, who was one of the members who launched "LINE" as the executive officer in charge of corporate business, and she will join us from 2021. In 2021, the latest functions of the disaster countermeasure system "respon:sum" were introduced in many hospitals, including the Osaka Acute and General Hospital and Chiba University Hospital. In the development of COVI-CO, a hospitalization coordination support system for expectant and nursing mothers infected with the new coronavirus, the cooperation with Chiba Prefecture made it possible to introduce and start operations as soon as possible. Currently, preparations are underway to begin using the system for the third round of vaccinations for medical personnel, and we are making progress in building a system that will deliver future medical care with peace of mind to as many people as possible.

■Business Policy for 2022
【1: Nationwide deployment of "Smart119," an emergency medical information service】
We will start a demonstration experiment in Yamanashi Prefecture, which has been adopted in 2021. Utilizing the results of this experiment, we will provide a flexible system throughout Japan that can meet the needs of each local government, optimized for regional characteristics such as population composition, climate, number of medical facilities, number of fire stations, and number of ambulances owned. We have already received many requests from municipalities and fire departments outside of Chiba Prefecture, and next year we plan to proceed with demonstration tests in cooperation with even more municipalities across Japan.

【2: Use of the COVI-CO Support System for Coordinating】
The problem of the delay of hospitalization for emergency patients by being rejected from multiple hospitals has been a social issue since before the coronavirus disaster. In particular, the hospitalization of pregnant and nursing women with Covid-19 is an urgent issue. We will promote the nationwide deployment of this system, which was introduced in Chiba Prefecture.

【3: Research and development to expand the target symptoms of AI predictive diagnosis algorithm】
The research and development of the AI predictive diagnosis algorithm, which has been put to practical use for stroke, will be continued in collaboration with the Department of Emergency and Intensive Care Medicine, Graduate School of Medicine, Chiba University. We plan to add acute cardiac disease as a new target.

＜About Smart119, Inc.＞
Smart119 Inc. is a start-up company established by an active emergency physician and originating from Chiba University School of Medicine.
Smart119 is a startup founded by an active emergency physician and originated from Chiba University School of Medicine. In order to "change the current '119'", Smart119 has developed and operates an emergency medical support system "Smart119" using voice recognition and AI.
In Chiba City, we are conducting a research and development project on emergency medical care for the Japan Agency for Medical Development (AMED).
Smart119 aims to "create future medical care with peace of mind.